Catalyst Wire Dossier Catalyst Wire Dossier

GIVLAARI

Givosiran · Alnylam Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for GIVLAARI, covering 2018-06-14 to 2025-05-08. Get the full timeline:

Most recent: EMA Authorised: Givlaari (Givosiran) — Alnylam Netherlands B.V.

See pricing